Pharma IQ Members


Korea’s Global Clinical Trial Magnetism

The rising presence of clinical trials (CT) in the Asia-Pacific region is predominantly driven by the East Asian region which includes China, Japan, Korea, Taiwan and Hong Kong. Over the past decade, Korea has become a global clinical trial hub and is one of the leading clinical trial destinations in the Asian region; with approximately 80% of its CTs being multinational trials from 2001-2012.

by: George Clinical Representative
Published: March 22, 2016
Tags: clinical, south korea, korea, clinical trial, clinical sites, multinational clinical study, local clinical study, Korea National Enterprise for Clinical Trials, KoNECT, CRO, contract research organisation, R&A